Provexis plc (PXS.L)

LSE • Currency in GBP

£0.74

-£0.03

-4.19%

Last Update: 17 Jul 2025, 15:35

£17.42M

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

£0.01 - £0.95

52 Week Range

PXS.L Stock Price Chart

Explore Provexis plc interactive price chart. Choose custom timeframes to analyze PXS.L price movements and trends.

There is nothing to show.

PXS.L Company Profile

Discover essential business fundamentals and corporate details for Provexis plc (PXS.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

28 Jun 2004

Employees

2.00

Website

https://www.provexis.com

CEO

Ian Ford BA ACA,

Description

Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

PXS.L Financial Timeline

Browse a chronological timeline of Provexis plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 29 Dec 2025

Earnings released on 27 Dec 2024

EPS came in at -£0.00, while revenue for the quarter reached £785.35K.

Earnings released on 27 Sept 2024

EPS came in at -£0.00, while revenue for the quarter reached £414.43K.

Earnings released on 29 Dec 2023

EPS came in at -£0.00, while revenue for the quarter reached £387.53K.

Earnings released on 28 Sept 2023

EPS came in at -£0.00, while revenue for the quarter reached £210.55K.

Earnings released on 30 Dec 2022

EPS came in at -£0.00, while revenue for the quarter reached £179.37K.

Earnings released on 31 Mar 2022

EPS came in at -£0.00, while revenue for the quarter reached £426.17K.

Earnings released on 30 Sept 2021

EPS came in at -£0.00, while revenue for the quarter reached £211.20K.

Earnings released on 31 Mar 2021

EPS came in at -£0.00, while revenue for the quarter reached £268.26K.

Earnings released on 30 Sept 2020

EPS came in at -£0.00, while revenue for the quarter reached £237.08K.

PXS.L Stock Performance

Access detailed PXS.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.